Dr Teo has published in many peer-reviewed journals on a host of topics in respiratory and intensive care medicine. She has, and continues to actively peer-review manuscripts for publication in many local and international journals, She is co-investigator for ongoing international phase III clinical trials currently being conducted in NUH, and is the current site principal investigator in a multi-centre national Interstitial Lung Disease (ILD) registry.

Dr Teo is regarded as a local and regional expert in ILD, and continues to actively contribute to advisory board meetings in Singapore and within the Asia-Pacific region. She is part of a consortium for many multi-centre ILD studies both locally and internationally.

Publications

1.      F Teo, LY Hsu, KN Lam, A Johan. Tetanus in an injecting buprenorphine abuser. Ann Acad Med Singapore 2007;36:1021-3

2.      F Teo, T Agasthian, AL Hsu. Recurrent foreign body granuloma with airway obstruction-is there a role for steroids? J Thorac Cardiovasc Surg 2008;136(1):224-5

3.      Hsu LY, Teo FS, Chin TM. Medical Biotechnology – Modern Development.
In Biotechnology [Doelle HW, DaSilva JS (ed)], in Encyclopedia of Life Support Systems (EOLSS). Developed under the auspices of UNESCO. 2007. EOLSS Publishers, Oxford, UK. URL: http://www.eolss.net/

4.      CS Tan, K Chan, C Chuah, HJ Ng, FK Cheah, F Teo, P Eng. Life Threatening and Occult Mediastinal Haemorrhage secondary to Acquired Factor VIII Deficiency. Ann Acad Med Singapore 2009; Mar;38(3):280-1.

5.      F Teo, D Anantham, D Feller-Kopman, A Ernst. Bronchoscopic management of sarcoidosis-related bronchial stenosis with adjuvant topical mitomycin C. Annals of Thoracic Surgery 2010; 89:2005-7

6.      Low SY, Teo F, Eng P, Tan PH. Pulmonary Sclerosing Hemangioma: pitfalls in management. Asian Cardiovasc Thorac Ann 2011; 19(2):139-42

7.      Phipps C, K Chan, F Teo, R Ponampalam. Fatal Chloroquine Poisoning: a rare cause of sudden cardiac arrest. Ann Acad Med Singapore 2011; 40(6):296-7

8.      L YA Chai, M Rauff, J Ong, A CL Kee, F SW Teo. Serratia septicaemia in pregnancy: further evidence to altered immune response to severe bacterial infection in pregnancy (letter). Journal of Infection 2011; 63, 480-81.

9.     Weixian Lee, Felicia SW Teo, Amelia Santosa, Gim Gee Teng. Churg-Strauss Syndrome Preceding Allergic Bronchopulmonary Aspergillosis. European Annals of Allergy and Clinical Immunology. European Annals of Allergy and Clinical Immunology 2015. Nov;47(6):228-31

10.   KF Phang, GG Teng, LLS Teo, JE Seet, CM Teoh, Felicia SW Teo. A 67-Year-Old Man With Psoriatic Arthritis and New-Onset Dyspnea. Chest 2018. 154 (5): e127-e134.

11.   F Teo, AU Wells. Diffuse parenchymal lung disease: An introduction. In John Firth, Christopher Conlon, and Timothy Cox (ed). Oxford Textbook of Medicine (6th edition). Oxford University Press, UK, 2020; 1-28.

12.   Lee PY, Oen KQX, Lim GRS, Hartono JL, Muthiah M, Huang DQ, Teo FSW, Li AY, Mak A, Chandran NS, Tan CL, Yang P, Tai ES, Ng KWP, Vijayan J, Chan YC, Tan LL, Lee MB-H, Chua HR, Hong WZ, Yap ES, Lim DK, Yuen YS, Chan YH, Aminkeng F, Wong ASC, Huang Y, Tay SH. Neutrophil-to-Lymphocyte Ratio Predicts Development of Immune-Related Adverse Events and Outcomes from Immune Checkpoint Blockade: A Case-Control Study. Cancers. 2021; 13(6):1308. https://doi.org/10.3390/cancers13061308

13.   Qing Hao Miow, Andres F. Vallejo, Yu Wang, Jia Mei Hong, Felicia S.W. Teo, Alvin D.Y. Wang, Hong Rong Loh, Tuan Zea Tan,Ying Ding, Hoi Wah She, Suay Hong Gan, Nicholas I. Paton, Josephine Lum, Cynthia Chee, Paul A. Tambyah, Amit Singhal, Marta E. Polak, Yee Tang Wang, Paul T. Elkington, Jon S. Friedland, Catherine W.M. Ong. Doxycycline as host-directed therapy in pulmonary tuberculosis: a Phase 2 randomized double-blind, placebo-controlled trial. J Clin Invest. 2021 Aug 2;131(15):e141895. 

14.   Wei Peng Yong, Felicia SW Teo, Lynette LS Teo, Matthew CH Ng, Tira J. Tan, Su Ying Low, Karmen Wong, Peter Ang, Su Pin Choo, Kim Hua Lee & Soo Chin Lee. Clinical best practices in optimal monitoring, early diagnosis, and effective management of antibody–drug conjugate-induced interstitial lung disease or pneumonitis: a multidisciplinary team approach in Singapore. Expert Opinion on Drug Metabolism & Toxicology 2023.       

15.  Tan YW, Agrawal RV, Pan TLT, Muthiah MD, Teo Felicia SW, Wong WH. Pentoxifylline therapy for persistent hepatopulmonary syndrome after liver transplantation. Singapore Med J 2023.

Clinical trials and research

1.    Site co-principal investigator for the following trials:

A phase III, randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of PRM-151 in patients with idiopathic pulmonary fibrosis

A phase III, open-label extension study to evaluate the long-term safety and efficacy of PRM-151 in patients with idiopathic pulmonary fibrosis

A double-blind, randomized, placebo-controlled trial evaluating the efficacy and safety of BI 1015550 over 52 weeks in patients with idiopathic pulmonary fibrosis

A double-blind, randomized, placebo-controlled trial evaluating the efficacy and safety of BI 1015550 over 52 weeks in patients with non-IPF progressive fibrosing interstitial lung disease

2.    Ongoing research grant awarded (site Principal investigator)

A prospective multi-centre study characterizing epidemiology and disease behaviour of interstitial lung disease in Singapore (ILD-Sing): an investigator-initiated non-interventional study funded by Boehringer-Ingelheim Singapore Pte Ltd.

3.    Co-investigator for study

Early use of tofacitinib with rituximab in patients with anti-MDA5 dermatomyositis with rapidly progressive interstitial lung disease.